Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jan Decloedt
Observed names:
Decloedt, Jan,
J Decloedt,
J. Decloedt,
Jan DeCloedt a,
Jan F. Decloedt
Institution:
AZ Sint-Blasius
Observed institutions:
Kantonsspital St. Gallen,
Leiden University Medical Center,
Universitair Ziekenhuis Leuven,
Ghent University Hospital,
Antwerp University Hospital,
Universitair Ziekenhuis Brussel,
Ziekenhuis Oost-Limburg,
AZ Sint-Blasius,
AZ Sint-Lucas,
AZ Sint-Maarten,
KU Leuven
show all 11
ORCID:
0000-0001-5812-1823
Observed ORCID:
0000-0001-5812-1823
OpenAlex ID:
A5020654856
Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients
1998
·
I. Vergote
, I. De Wever
, et al.
·
Gynecologic Oncology
·
380
Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: Can the risk be reduced?
1999
·
Peter A. van Dam
, Jan DeCloedt a
, et al.
·
American Journal of Obstetrics and Gynecology
·
129
Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
2000
·
I B Vergote
, I De Wever
, et al.
·
PubMed
·
92
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial
2018
·
Patrick Neven
, Lynn Jongen
, et al.
·
Clinical Cancer Research
·
61
PDF
Interval debulking surgery: An alternative for primary surgical debulking?
2000
·
Ignace Vergote
, Ivo De Wever
, et al.
·
Seminars in Surgical Oncology
·
36
Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial
2019
·
Patrice Forget
, Gauthier Bouche
, et al.
·
PLoS ONE
·
27
PDF
The Feasibility of Open Laparoscopy in Gynecologic–Oncologic Patients
1997
·
J. Decloedt
, P. Berteloot
, et al.
·
Gynecologic Oncology
·
23
Breast cancer prevention: lifestyle changes and chemoprevention.
2011
·
S Lambrechts
, J Decloedt
, et al.
·
PubMed
·
22
Case report of a poorly differentiated uterine tumour with t(10;17) translocation and neuroectodermal phenotype.
2011
·
Frédéric Amant
, Thomas Tousseyn
, et al.
·
PubMed
·
19
Outpatient hysteroscopy: indications and hysteroscopic findings in pre‐ and postmenopausal patients
1999
·
Jan F. Decloedt
, David W. Fenton
·
Gynaecological Endoscopy
·
13
Variability in hospital treatment costs: a time-driven activity-based costing approach for early-stage invasive breast cancer patients
2020
·
Erin Roman
, Brecht Cardoen
, et al.
·
BMJ Open
·
12
PDF
Treatment of the severe or recurrent inverted nipple by interposition of a resorbable polydioxanone sheet
2009
·
Geert Peeters
, Jan Decloedt
, et al.
·
Journal of Plastic Reconstructive & Aesthetic Surgery
·
11
Laparoscopy in gynaecologic oncology: a review
1999
·
J. Decloedt
, I. Vergote
·
Critical Reviews in Oncology/Hematology
·
7
Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres – A population-based study in Belgium
2024
·
Roos Leroy
, Geert Silversmit
, et al.
·
European Journal of Cancer
·
4
Prospective study evaluating the effect of impaired tamoxifen metabolisation on efficacy in breast cancer patients receiving tamoxifen in the neo-adjuvant or metastatic setting.
2016
·
Anneleen Lintermans
, Kathleen Van Asten
, et al.
·
Journal of Clinical Oncology
·
4
Diagnostic laparoscopy to assess operability of advanced ovarian cancer: a feasibility study
1997
·
Peter van Dam
, Jan Decloedt
, et al.
·
4
The prognostic role of the androgen receptor in patients with triple-negative early breast cancers and primary surgery.
2019
·
Lynn Jongen
, Giuseppe Floris
, et al.
·
Journal of Clinical Oncology
·
2
Abstract P3-07-46: CYPTAM-BRUT 3: Endometrial thickness cannot be used as a marker for tamoxifen metabolization in postmenopausal breast cancer patients
2016
·
A Poppe
, A-S Dieudonné
, et al.
·
Cancer Research
·
2
The Impact of Breast Cancer Surgery on Sexual Functioning: A Retrospective Online Survey “Do scars really matter?”
2026
·
Nynke Elisabeth Willers
, Paul Enzlin
, et al.
·
SSRN Electronic Journal
Table S2 from Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial
2023
·
Patrick Neven
, Lynn Jongen
, et al.
Figure S3 from Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial
2023
·
Patrick Neven
, Lynn Jongen
, et al.
Figure S4 from Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial
2023
·
Patrick Neven
, Lynn Jongen
, et al.
Table S1 from Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial
2023
·
Patrick Neven
, Lynn Jongen
, et al.
Figure S2 from Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial
2023
·
Patrick Neven
, Lynn Jongen
, et al.
Figure S1 from Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial
2023
·
Patrick Neven
, Lynn Jongen
, et al.
Show more works
View as search
Works count:
42
Citation count:
848
H-index:
11
I10-index:
12
Year
Topic
Type
